Bumm P, Müller E C, Grimm-Müller U, Schlimok G
Krankenhaus Zweckverband Augsburg HNO-Klinik.
Laryngorhinootologie. 1991 May;70(5):260-6. doi: 10.1055/s-2007-998033.
In patients with various otoneurological diseases like hearing loss, neuronitis vestibularis, Ménière's disease and Bell's palsy, analyses concerning the immunoregulation and immunogenetics were done. For analysing the immunoregulation the T-helper (CD4) T-suppressor (CD8) ratio was determined. In contrast to patients with hearing loss caused by otobasal fractures and a healty control group, this ratio was elevated in 50% of the patients suffering from hearing loss. The elevation of the CD4/CD8 ratio was mainly caused by a reduction of CD8 positive cytotoxic-suppressor T-lymphocytes. The CD4/CD8 ratio may be of prognostic value, since an elevated ratio was found more often in patients with relapse of hearing loss, fluctuations, persistence of tinnitus or vestibular symptoms. An elevated ratio could also be detected in 48% of the patients with neuronitis vestibularis, in 50% of the patients with Ménière's disease and in 39% of the patients with Bell's palsy. A normal value was found in paralysis of the facial nerve of known origin like a state after trauma or after herpes zoster oticus paralysis. Immunogenetics was tested by HLA-DR typing. In patients with hearing loss HLA-DR4 antigen was distinctly increased, the relative risk was 2.8. The presence of the HLA-DR4 antigen proved to be an unfavourable sign, since in 44% of the patients presenting these antigens we found no improvement of the hearing. In patients with neuronitis vestibularis we found a relative risk of 3.12 and in patients with Ménière's disease a relative risk of 3.64, both for HLA-DR4.(ABSTRACT TRUNCATED AT 250 WORDS)
对患有各种耳神经科疾病(如听力损失、前庭神经炎、梅尼埃病和贝尔麻痹)的患者进行了免疫调节和免疫遗传学分析。为分析免疫调节,测定了辅助性T细胞(CD4)与抑制性T细胞(CD8)的比例。与因耳基底骨折导致听力损失的患者及健康对照组相比,50%的听力损失患者该比例升高。CD4/CD8比例升高主要是由于CD8阳性细胞毒性抑制性T淋巴细胞减少。CD4/CD8比例可能具有预后价值,因为在听力损失复发、波动、耳鸣或前庭症状持续的患者中,该比例升高更为常见。48%的前庭神经炎患者、50%的梅尼埃病患者和39%的贝尔麻痹患者也可检测到比例升高。在已知病因的面神经麻痹患者(如创伤后或耳部带状疱疹麻痹后的状态)中发现该比例正常。通过HLA - DR分型检测免疫遗传学。在听力损失患者中,HLA - DR4抗原明显增加,相对风险为2.8。HLA - DR4抗原的存在被证明是一个不利迹象,因为在出现这些抗原的患者中,44%的患者听力没有改善。在前庭神经炎患者中,HLA - DR4的相对风险为3.12,在梅尼埃病患者中为3.64。(摘要截断于250字)